Tendence Capital to Release Q2 2016 Smart Health Entrepreneurship and Investment Analysis Report on July 7
In March 2015, the Ministry of Science and Technology convened China’s first expert meeting on precision medicine strategy, proposing the National Precision Medicine Initiative. The meeting indicated that China would invest RMB 60 billion in the field of precision medicine by 2030.
In March 2016, precision medicine was included in the National Key R&D Program, which will promote the inclusion of precision medical services in the national medical insurance reimbursement list. This move is expected to break through the key bottleneck hindering the large-scale commercialization of precision medicine, potentially ushering in a period of explosive growth for the entire industry in the coming years.
The development of precision medicine in this context has not been smooth; in fact, the entire industry still faces numerous pain points.
The most core and fundamental challenge facing precision medicine still stems from the technology itself.
To promote the widespread adoption of precision medicine, it is essential to continuously advance its medical technologies. This will address key challenges such as genomic sequencing, data analysis, and the heterogeneity of patient populations, thereby enabling a gradual reduction in the cost of precision medicine treatments.
To this end, Tongdu Capital will host the “Tongdu Time – Precision Medicine: Innovative Technologies and Business Models in Oncology” salon in Beijing on the afternoon of July 7, 2016. Yang Chengkui, Vice President of Investment at Tongdu Capital, willMajor Release: Latest Smart Health Startup and Investment & Financing Analysis Report for Q2 2016, sharing extensive data on the latest developments in digital health. (This report is a quarterly series authored by Tongdu Capital, which primarily summarizes and forecasts entrepreneurial and investment/financing trends in the digital health sector through analysis of segmented markets.)
At that time,Mr. Sun Wenxiang, Lekang Think TankWill provide the latest policy interpretation of the report;Mr. Gao Xianshu, Director of the Department of Radiation Oncology, Peking University First Hospital; Mr. Hu Zhiyuan, Director of the Laboratory of Nanotranslational Medicine, National Center for Nanoscience and TechnologyThe event will also feature keynote speeches that share profound insights into the intersection of oncology and business models. Founders and CEOs of numerous internet healthcare projects, along with leading investors, will gather to discuss what new opportunities are emerging for cancer treatment in the era of precision medicine, and what innovative business models are on the rise.
[Organizer]Tongdu Capital, Tsinghua SEM Entrepreneur Accelerator, VCBeat
[Media Cooperation]Investment Circle, Yiou.com, 36Kr (More invited media to be updated continuously......)
[Event Duration]July 7, 2016, 13:30–17:30
[Event Location]3rd Floor, Haohai Building, Zhongguancun Innovation Street, No. 36 Haidian West Street, Haidian District, Beijing (Enter via the north entrance of the Haohai Building office area, above the JD.com Milk Tea & Coffee shop)
[Event Agenda]
Time | Content |
1:30-2:00 | Check-in and Networking |
2:00-2:10 | Address Wu Ronghui, Founding Managing Partner of Tongdu Capital |
2:10-2:40 | Release and Interpretation: Smart Health Entrepreneurship and Investment & Financing Analysis Report (2016Q2) Macroeconomic Policy Interpretation – Sun Wenxiang (Lekang Think Tank) |
2:40-4:10 | Thematic Sharing on Technology and Business Models in Oncology: 45 Minutes per Person |
Keynote Speech I: Gao Xianshu (Director, Department of Radiation Oncology, Peking University First Hospital) | |
Keynote Speech II: Hu Zhiyuan (Director of the Laboratory for Nano-Translational Medicine, National Center for Nanoscience and China; Founder of "Tumor Catcher") | |
4:10-5:20 | Seminar Salon: Does Mobile Health Play a Role in Cancer Treatment? |
Forum Moderator: Qiao Jiying, Partner at Tongdu Capital Panelist: Wu Ronghui, Founding Managing Partner of Tongdu Capital Ni Jianwen, CEO of Ping An Health Cloud Li Xiaomin, Partner at Chunfeng Venture Capital Zhang Yang, Founder of Purun Kangqiao Zhang Tianze, Founder of LINK-CARE Wu Wenhui, Founder of Jiufeng Medical Wang Jiejun, Founder of Kang'ai Doctor |
Event guests are subject to final on-site participation! Thank you for your support!
We warmly welcome professionals from the health and wellness industry to join us. For more information about our events, please contact the staff listed below.
Event Registration Link:http://m.grouplus.cn/4mmz9w
【Salon Contact】
Tongdu Capital Su Danping 13520922185 Email:susan@tendencevc.com
Tongdu Capital Shen Ying 13811774229 Email:Azona@tendencevc.com